178 related articles for article (PubMed ID: 28923773)
1. Plasma separation using a membrane.
Hirano R; Namazuda K; Suemitsu J; Harashima T; Hirata N
Transfus Apher Sci; 2017 Oct; 56(5):649-653. PubMed ID: 28923773
[TBL] [Abstract][Full Text] [Related]
2. Double filtration plasmapheresis: Review of current clinical applications.
Hirano R; Namazuda K; Hirata N
Ther Apher Dial; 2021 Apr; 25(2):145-151. PubMed ID: 32558286
[TBL] [Abstract][Full Text] [Related]
3. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
4. Current topics in therapeutic plasmapheresis.
Nakanishi T; Suzuki N; Kuragano T; Nagasawa Y; Hasuike Y
Clin Exp Nephrol; 2014 Feb; 18(1):41-9. PubMed ID: 23887747
[TBL] [Abstract][Full Text] [Related]
5. Massive hollow fiber clotting: a distinct problem in treatment of cryoglobulinemia by membrane plasmapheresis.
Lai KN; Cheng SC; Vallance-Owen J
Artif Organs; 1987 Jun; 11(3):259-64. PubMed ID: 3113406
[TBL] [Abstract][Full Text] [Related]
6. Selective plasma exchange.
Ohkubo A; Okado T
Transfus Apher Sci; 2017 Oct; 56(5):657-660. PubMed ID: 28939369
[TBL] [Abstract][Full Text] [Related]
7. Selective removal of triglyceride-rich lipoproteins by plasmapheresis in diabetic patients with severe hypertriglyceridemia.
Ito H; Naito C; Hayashi H; Kawamura M; Miyazaki S
Artif Organs; 1989 Jun; 13(3):190-6. PubMed ID: 2764758
[TBL] [Abstract][Full Text] [Related]
8. Asparaginase-associated concurrence of hyperlipidemia, hyperglobulinemia, and thrombocytosis was successfully treated by centrifuge/membrane hybrid double-filtration plasmapheresis.
Wang T; Xu B; Fan R; Liu Z; Gong D
J Clin Lipidol; 2016; 10(3):646-9. PubMed ID: 27206953
[TBL] [Abstract][Full Text] [Related]
9. Protocol of comparison of the effects of single plasma exchange and double filtration plasmapheresis on peripheral lymphocyte phenotypes in patients with Chronic Inflammatory Demyelinating Polyradiculoneuropathy: a monocentric prospective study with single-case experimental design.
Moranne O; Ion IM; Cezar R; Messikh Z; Prelipcean C; Chkair S; Thouvenot E; Tran TA; Corbeau P; Chevallier T
BMC Neurol; 2022 Aug; 22(1):293. PubMed ID: 35931957
[TBL] [Abstract][Full Text] [Related]
10. [Removal ability of immunoglobulins in plasma exchange and double-filtration plasmapheresis].
Tagawa Y; Yuki N
Rinsho Shinkeigaku; 1997 May; 37(5):410-2. PubMed ID: 9294330
[TBL] [Abstract][Full Text] [Related]
11. Plasma separator Plasmaflo OP.
Hirata N; Shizume Y; Shirokaze J; Suemitsu J; Yoshida H; Yamawaki N
Ther Apher Dial; 2003 Feb; 7(1):64-8. PubMed ID: 12921117
[TBL] [Abstract][Full Text] [Related]
12. Comparative study of clinical effects between plasma adsorption and double filtration plasmapheresis in patients with myasthenia gravis.
Okada H; Moriwaki K; Sugahara S; Nakamoto H; Hosokawa T; Hamaguchi K; Suzuki H
Ther Apher; 1997 Nov; 1(4):343-7. PubMed ID: 10225728
[TBL] [Abstract][Full Text] [Related]
13. [Comparison of plasma exchange (PEX) vs. double filtration plasmapheresis (DFPP) with or without steroid administration in a case of MPO-ANCA-positive immune complex type crescentic glomerulonephritis].
Ito C; Ando Y; Akimoto T; Kusano E; Asano Y
Nihon Jinzo Gakkai Shi; 2000 Jul; 42(5):374-80. PubMed ID: 10998918
[TBL] [Abstract][Full Text] [Related]
14. More selective removal of myeloperoxidase-anti-neutrophil cytoplasmic antibody from the circulation of patients with vasculitides using a novel double-filtration plasmapheresis therapy.
Gong D; Ji D; Xu B; Liu Z
Ther Apher Dial; 2013 Feb; 17(1):93-8. PubMed ID: 23379500
[TBL] [Abstract][Full Text] [Related]
15. Removal kinetics of antibodies against glutamic acid decarboxylase by various plasmapheresis modalities in the treatment of neurological disorders.
Ohkubo A; Okado T; Kurashima N; Maeda T; Miyamoto S; Nakamura A; Seshima H; Iimori S; Sohara E; Uchida S; Rai T
Ther Apher Dial; 2014 Jun; 18(3):231-7. PubMed ID: 24965288
[TBL] [Abstract][Full Text] [Related]
16. Plasma adsorption in critical care.
Yang KS; Kenpe K; Yamaji K; Tsuda H; Hashimoto H
Ther Apher; 2002 Jun; 6(3):184-8. PubMed ID: 12109940
[TBL] [Abstract][Full Text] [Related]
17. Continuous monitoring of blood volume in double filtration plasmapheresis.
Mineshima M; Eguchi K; Horibe K; Yokoi R; Kaneko I; Kimata N; Sanaka T; Nihei H; Agishi T
ASAIO J; 1998; 44(5):M465-9. PubMed ID: 9804474
[TBL] [Abstract][Full Text] [Related]
18. [Plasmapheresis with membrane type plasma separator].
Michikojima A
Nihon Rinsho; 2004 May; 62 Suppl 5():313-8. PubMed ID: 15197936
[No Abstract] [Full Text] [Related]
19. Membrane plasmapheresis in the United States: a review over the last 20 years.
Siami GA; Siami FS
Ther Apher; 2001 Aug; 5(4):315-20. PubMed ID: 11724518
[TBL] [Abstract][Full Text] [Related]
20. Effect of membrane trapping in plasma fractionator on separative characteristics.
Mineshima M; Agishi T; Hasuo Y; Kaneko I; Era K; Ota K
Int J Artif Organs; 1988 May; 11(3):191-4. PubMed ID: 3403057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
